Timothy P. Walbert - 30 Mar 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
Chairman, President and CEO, Director
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol
HZNP
Transactions as of
30 Mar 2022
Transactions value $
-$5,262,787
Form type
4
Filing time
01 Apr 2022, 16:10:02 UTC
Previous filing
25 Mar 2022
Next filing
08 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Sale -$1.52M -14.5K -2.71% $104.61 521K 30 Mar 2022 Direct F1, F2
transaction HZNP Ordinary Shares Sale -$3.74M -35.5K -6.81% $105.52 486K 30 Mar 2022 Direct F1, F3
holding HZNP Ordinary Shares 108K 30 Mar 2022 See footnote F4
holding HZNP Ordinary Shares 100K 30 Mar 2022 See footnote F5
holding HZNP Ordinary Shares 40.9K 30 Mar 2022 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.00 to $105.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.01 to $105.925 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The shares are held by the Timothy P. Walbert 2021 Gift Trust, of which the Reporting Person's spouse is the Trustee and beneficiary.
F5 The shares are held by the Keli B. Walbert 2021 Gift Trust, of which the Reporting Person is the Trustee. The beneficiaries of the Trust include the Reporting Person and his descendants.